Evidence map›Paper›PMID 37292445›Full record

ArticleJournal of medical signals and sensors

A GU-Net-Based Architecture Predicting Ligand-Protein-Binding Atoms.

Fatemeh Nazem, Fahimeh Ghasemi, Afshin Fassihi, Reza Rasti, Alireza Mehri Dehnavi

Abstract read
In one paragraph

Article in Journal of medical signals and sensors. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Fatemeh NazemDepartment of Bioelectrics and Biomedical Engineering, School of Advanced Technologies in Medicine, Isfahan University of Medical Sciences, Isfahan, Iran.
Fahimeh GhasemiDepartment of Bioinformatics and Systems Biology, School of Advanced Technologies in Medicine, Isfahan University of Medical Sciences, Isfahan, Iran.
Afshin FassihiDepartment of Medicinal Chemistry, School of Pharmacology and Pharmaceutical Sciences, Isfahan University of Medical Sciences, Isfahan, Iran.
Reza RastiDepartment of Biomedical Engineering, Faculty of Engineering, University of Isfahan, Isfahan, Iran.
Alireza Mehri DehnaviDepartment of Bioelectrics and Biomedical Engineering, School of Advanced Technologies in Medicine, Isfahan University of Medical Sciences, Isfahan, Iran.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: The first step in developing new drugs is to find binding sites for a protein structure that can be used as a starting point to design new antagonists and inhibitors. The methods relying on convolutional neural network for the prediction of binding sites have attracted much attention. This study focuses on the use of optimized neural network for three-dimensional (3D) non-Euclidean data. Methods: A graph, which is made from 3D protein structure, is fed to the proposed GU-Net model based on graph convolutional operation. The features of each atom are considered as attributes of each node. The results of the proposed GU-Net are compared with a classifier based on random forest (RF). A new data exhibition is used as the input of RF classifier. Results: The performance of our model is also examined through extensive experiments on various datasets from other sources. GU-Net could predict the more number of pockets with accurate shape than RF. Conclusions: This study will enable future works on a better modeling of protein structures that will enhance knowledge of proteomics and offer deeper insight into drug design process.

Indexed as

Graph convolutional neural networkpoint cloud semantic segmentationprotein–ligand-binding sitesthree-dimensional U-Net model

Identifiers

PMID37292445
PMCPMC10246592

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.